Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02).
about
Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Neoadjuvant Treatment of Stage ...... ase II Study (GBECAM 2008/02).
@en
Neoadjuvant Treatment of Stage ...... ase II Study (GBECAM 2008/02).
@nl
type
label
Neoadjuvant Treatment of Stage ...... ase II Study (GBECAM 2008/02).
@en
Neoadjuvant Treatment of Stage ...... ase II Study (GBECAM 2008/02).
@nl
prefLabel
Neoadjuvant Treatment of Stage ...... ase II Study (GBECAM 2008/02).
@en
Neoadjuvant Treatment of Stage ...... ase II Study (GBECAM 2008/02).
@nl
P2093
P2860
P356
P1476
Neoadjuvant Treatment of Stage ...... hase II Study (GBECAM 2008/02)
@en
P2093
José Bines
Otto Metzger-Filho
Roberta M B Sarmento
P2860
P356
10.3389/FONC.2017.00329
P577
2017-01-01T00:00:00Z